| Favorable NMR metabotype (n = 127)* | Unfavorable NMR metabotype (n = 76)** |
---|---|---|
n (%) | ||
 Men | 30 (23.6) | 40 (52.6) |
 Statin users | 22 (17.3) | 7 (9.2) |
 Anti-inflammatory drug users | 7 (5.5) | 0 (0) |
 Premenopausal women | 54 (56) | 12 (33) |
 Women using hormonal contraceptives | 29 (30) | 3 (8) |
Mean (SD) | ||
 Age (years) | 49 (13) | 51 (11) |
 BMI (kg/m2) | 31.8 (5.1) | 32.7 (4.9) |
 Waist circumference (cm) | 105.0 (14.5) | 109.6 (12.8) |
 HbA1c (mmol/mol) | 29 (15) | 32 (16) |
 Total-C (mmol/L) | 4.6 (0.8) | 5.7 (0.9) |
 LDL-C (mmol/L) | 3.0 (0.7) | 4.1 (0.9) |
 Median (IQR) | ||
 HDL-C (mmol/L) | 1.4 (0.5) | 1.1 (0.3) |
 Triglycerides (mmol/L) | 1.06 (0.45) | 1.9 (0.99) |
 Lp(a) (mg/L) | 309 (531) | 227 (341) |
 Fasting glucose (mmol/L) | 5.1 (0.9) | 5.5 (0.9) |
 Insulin (pmol/L) | 68 (59) | 96 (71) |
 2-h glucose (mmol/L) | 5.1 (2.2) | 5.8 (2.5) |
 Systolic BP (mmHg) | 117 (18) | 123 (17) |
 Diastolic BP (mmHg) | 70 (12) | 73 (14) |
 CRP (mg/L) | 2.5 (3.7) | 3.3 (4.8) |